Emilya Huseynova: Excited to Share That My Work On Blood Safety Monitoring Has Just Been Published by Transfusion
Emilya Huseynova, Principal Scientist in Clinical Research at The American Red Cross, shared on LinkedIn:
”I am excited to share that my work on blood safety monitoring has just been published by Transfusion.
This research became possible because of the hard work of my science team at the Transfusion Safety and Surveillance, American Red Cross and our collaborators at Vitalant, OneBlood, New York Blood Center, and the FDA.
Our continuous national monitoring of the safety of blood donations shows that expanded donor eligibility due to updated FDA guidance from 12-month deferral to 3-month deferral for certain high-risk behaviors has not negatively impacted the prevalence of the major transfusion-transmissible infections in the US blood.
We continue our critical work to gather data and to evaluate the newest updates to donor deferral policy by FDA based on individualized donor assessment that became effective in 2023, to ensure the safety of our blood donations for our transfusion patients.
You can read more about our work here.”
Read the full article here.
Article: Prevalence of HIV, HBV, and HCV in United States blood donations, 2015–2023: The transfusion-transmissible infections monitoring system (TTIMS)
Authors: Emilya Huseynova, James Haynes, Edward P. Notari, Brian Custer, Rita Reik, Jed Gorlin, Artur Belov, Hong Yang, Roger Y. Dodd, Susan L. Stramer

Stay updated on all scientific advances in the field of Transfusion Medicine with Hemostasis Today.
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM